litlas
ログインアカウント作成

Martin Kolb

2001–2025 年に発表

175
論文数
28,273
被引用数
81
h 指数
164
i10 指数

被引用数

Martin Kolb の年別被引用数1993 年: 被引用 1 件2001 年: 被引用 6 件2002 年: 被引用 19 件2003 年: 被引用 51 件2004 年: 被引用 51 件2005 年: 被引用 71 件2006 年: 被引用 67 件2007 年: 被引用 91 件2008 年: 被引用 75 件2009 年: 被引用 113 件2010 年: 被引用 109 件2011 年: 被引用 100 件2012 年: 被引用 101 件2013 年: 被引用 102 件2014 年: 被引用 115 件2015 年: 被引用 162 件2016 年: 被引用 200 件2017 年: 被引用 265 件2018 年: 被引用 263 件2019 年: 被引用 1,012 件2020 年: 被引用 1,299 件2021 年: 被引用 1,433 件2022 年: 被引用 1,231 件2023 年: 被引用 1,010 件2024 年: 被引用 1,684 件2025 年: 被引用 743 件2026 年: 被引用 19 件1994〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,594 件、この内訳の 22.7%中国: 引用元論文 1,312 件、この内訳の 11.5%イギリス: 引用元論文 850 件、この内訳の 7.4%ドイツ: 引用元論文 736 件、この内訳の 6.4%イタリア: 引用元論文 602 件、この内訳の 5.3%カナダ: 引用元論文 578 件、この内訳の 5.1%日本: 引用元論文 536 件、この内訳の 4.7%フランス: 引用元論文 508 件、この内訳の 4.5%オーストラリア: 引用元論文 350 件、この内訳の 3.1%オランダ: 引用元論文 296 件、この内訳の 2.6%スペイン: 引用元論文 287 件、この内訳の 2.5%韓国: 引用元論文 243 件、この内訳の 2.1%
0%22.7%その他 22.1%

機関

分野

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology12%
  • Immunology and Microbiology3.7%
  • Engineering0.8%
  • Neuroscience0.6%
  • Environmental Science0.5%
  • その他2.6%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis19.8%
  • Systemic Sclerosis and Related Diseases4.3%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.7%
  • Pulmonary Hypertension Research and Treatments3%
  • Sarcoidosis and Beryllium Toxicity Research2.9%
  • Neonatal Respiratory Health Research2.7%
  • その他63.6%

共著者

全論文

検索で開く
  1. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

    著者: Luca Richeldi, Roland M. du Bois, Ganesh Raghu, Arata Azuma, Kevin M. Brown, Ulrich Costabel, Vincent Cottin, Kevin R. Flaherty, David M. Hansell, Yoshikazu Inoue, Dong Soon Kim, Martin Kolb, Andrew G. Nicholson, Paul W. Noble, Moisés Selman, Hiroyuki Taniguchi, Michèle Brun, Florence Le Maulf, M Girard, Susanne Stowasser, Rozsa Schlenker‐Herceg, Bernd Disse, Harold R. Collard - New England Journal of Medicine 2014 被引用: 4,611

  2. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

    著者: Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Simon Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser, Carl Coeck, Emmanuelle Clerisme-Beaty, Bernd Rosenstock, Manuel Quaresma, Thomas Haeufel, Rainer-Georg Goeldner, Rozsa Schlenker‐Herceg, Kevin K. Brown - New England Journal of Medicine 2019 被引用: 2,346

  3. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

    著者: Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin Hostettler, Susanne Stowasser, Martin Kolb - European Respiratory Journal 2015 被引用: 986

  4. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    著者: Harold R. Collard, Christopher J. Ryerson, Tamera J. Corte, Gísli Jenkins, Yasuhiro Kondoh, David J. Lederer, Joyce Lee, Toby M. Maher, Athol U. Wells, Κατερίνα Αντωνίου, Jürgen Behr, Kevin M. Brown, Vincent Cottin, Kevin R. Flaherty, Junya Fukuoka, David M. Hansell, Takeshi Johkoh, Naftali Kaminski, Dong Soon Kim, Martin Kolb, David A. Lynch, Jeffrey L. Myers, Ganesh Raghu, Luca Richeldi, Hiroyuki Taniguchi, Fernando J. Martínez - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 1,444

  5. Idiopathic pulmonary fibrosis: state of the art for 2023

    著者: Anna J. Podolanczuk, Carey C. Thomson, Martine Rémy‐Jardin, Luca Richeldi, Fernando J. Martínez, Martin Kolb, Ganesh Raghu - European Respiratory Journal 2023 被引用: 320

  6. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    著者: Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim Wuyts, Susanne Stowasser, Manuel Quaresma, Rainer-Georg Goeldner, Rozsa Schlenker‐Herceg, Martin Kolb, Shuichi Abe, Myriam Aburto, Orlando Acosta, Charles Andrews, Danielle Antin‐Ozerkis, German Arce, Manuel Arias, С. Н. Авдеев, Adam Barczyk, Rebecca Bascom, Е. Д. Баздырев, Paul Beirne, Elizabeth A. Belloli, Miguel Bergna, Emmanuel Bergot, Nitin Bhatt, Stefan Blaas, Benjamin Bondue, Francesco Bonella, E. James Britt, Ketan Buch, John R. Burk, Hourong Cai, André M. Cantin, D.M. Castillo Villegas, Agustina Díaz Cazaux, Stefania Cerri, Said Chaaban, Nazia Chaudhuri, Vincent Cottin, Bruno Crestani, Gerard J. Criner, Caroline Dahlqvist, Sonye K. Danoff, J. Dematte D'Amico, Daniel F. Dilling, Paulo Eduardo Elias, Neil Ettinger, Jeremy Falk, Evans R. Fernández Pérez, A. Gamez-Dubuis, G. Giessel, Alex H. Gifford, Marilyn K. Glassberg, Craig S. Glazer, Jeffrey A. Golden, Luis Gómez Carrera, Julien Guiot, Robert W. Hallowell, Hiroki Hayashi, J. Hetzel, Nik Hirani, L. Homik, Benjamin Hope-Gill, David Hotchkin, Kazuya Ichikado, M. M. Ilkovich, Yoshikazu Inoue, Shinyu Izumi, Ewa Jassem, Leonie Jones, S. Jouneau, Robert J. Kaner, Jian Kang, Tsuyoshi Kawamura, Romain Kessler, Y. Kim, Kazuma Kishi, Hideya Kitamura, Martin Kolb, Yasuhiro Kondoh, Chiyoko Kono, Dirk Koschel, Michael Kreuter, Tejaswini Kulkarni, Jan Kuś, F. Lebargy, Antonio León Jiménez, Qun Luo, Yolanda Mageto, Toby M. Maher, Shigeki Makino, S. Marchand‐Adam, Charles‐Hugo Marquette, Raquel Martínez, Martin Ulises Gutierrez Martinez ほか 68 名 - The Lancet Respiratory Medicine 2020 被引用: 559

  7. Progressive pulmonary fibrosis: an expert group consensus statement

    著者: Sujeet Rajan, Vincent Cottin, Raja Dhar, Sonye K. Danoff, Kevin R. Flaherty, Kevin K. Brown, Anant Mohan, Elizabeth Renzoni, Murali Mohan, Zarir Udwadia, Padmanabha Shenoy, David C. Currow, Anand Devraj, Bhavin Jankharia, Ritu Kulshrestha, Steve Jones, Claudia Ravaglia, Sílvia Quadrelli, Rajam K Iyer, Sahajal Dhooria, Martin Kolb, Athol U. Wells - European Respiratory Journal 2022 被引用: 233

  8. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

    著者: Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie, Martin Kolb - The International Journal of Biochemistry & Cell Biology 2007 被引用: 994

  9. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    著者: Joshua J. Solomon, Sonye K. Danoff, Felix Woodhead, Shelley Hurwitz, Rie Maurer, Ian Glaspole, Paul F. Dellaripa, Bibek Gooptu, Robert Vassallo, Gerard Cox, Kevin R. Flaherty, Huzaifa Adamali, Michael Gibbons, Lauren Troy, Ian Forrest, Joseph A. Lasky, Lisa Spencer, Jeffrey A. Golden, Mary Beth Scholand, Nazia Chaudhuri, Mark A. Perrella, David A. Lynch, Daniel C. Chambers, Martin Kolb, Cathie Spino, Ganesh Raghu, Hilary J. Goldberg, Iván O. Rosas, Shana Haynes-Harp, F. Poli, Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy J. Doyle, Anthony H. Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen M. Humphries, John Huntwork, Chris Glynn, Steve Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz‐Odrobina, Reba Bissell, Mark H. Wener, Lisa Lancaster, Leslie J. Crawford, Karmela K Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria Kokosi, Matthew Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie Fletcher, Paul Beirne, C Favager, Jo Brown, Julie Dawson ほか 7 名 - The Lancet Respiratory Medicine 2022 被引用: 208

  10. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

    著者: Gísli Jenkins, Bethany B. Moore, Rachel C. Chambers, Oliver Eickelberg, Mélanie Königshoff, Martin Kolb, Geoffrey J. Laurent, Carmel B. Nanthakumar, Mitchell A. Olman, Annie Pardo, Moisés Selman, Dean Sheppard, Patricia J. Sime, Andrew M. Tager, Amanda L. Tatler, Victor J. Thannickal, Eric S. White - American Journal of Respiratory Cell and Molecular Biology 2017 被引用: 431

  11. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    著者: David J. Lederer, Scott C. Bell, Richard D. Branson, James D. Chalmers, Rachel Marshall, David M. Maslove, David E. Ost, Naresh M. Punjabi, Michael Schätz, Alan R Smyth, Paul W. Stewart, Samy Suissa, Alex A. Adjei, Cezmi A. Akdiş, Élie Azoulay, Jan Bakker, Zuhair K. Ballas, Philip G. Bardin, Esther Barreiro, Rinaldo Bellomo, Jonathan A. Bernstein, Vito Brusasco, Timothy G. Buchman, Sudhansu Chokroverty, Nancy A. Collop, James D. Crapo, Dominic A. Fitzgerald, Lauren Hale, Nicholas Hart, Felix Herth, Theodore J. Iwashyna, Gísli Jenkins, Martin Kolb, Guy B. Marks, Peter J. Mazzone, J. Randall Moorman, Thomas M. Murphy, Terry L. Noah, Paul N. Reynolds, Dieter Riemann, Richard Russell, Aziz Sheikh, Giovanni Sotgiu, Erik R. Swenson, Rhonda D. Szczesniak, Ronald Szymusiak, Jean–Louis Teboul, Jean‐Louis Vincent - Annals of the American Thoracic Society 2018 被引用: 722

  12. The importance of interventional timing in the bleomycin model of pulmonary fibrosis

    著者: Philipp Kolb, Chandak Upagupta, Megan Vierhout, Ehab Ayaub, Pierre Simon Bellaye, Jack Gauldie, Chiko Shimbori, Mark D. Inman, Kjetil Ask, Martin Kolb - European Respiratory Journal 2020 被引用: 199

  13. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

    著者: Nathan Hambly, Mohammed A. Farooqi, Anna Dvorkin‐Gheva, Kathryn Donohoe, Kristopher Garlick, Ciaran Scallan, Sy Giin Chong, S. Macisaac, Deborah Assayag, Kerri A. Johannson, Charlene D. Fell, Veronica Marcoux, H. Manganas, Julie Morisset, Alessia Comes, Jolene H. Fisher, Shane Shapera, Andrea S. Gershon, Teresa To, Alyson W. Wong, Mohsen Sadatsafavi, Pierce G. Wilcox, Andrew J. Halayko, Nasreen Khalil, Gerard Cox, Luca Richeldi, Christopher J. Ryerson, Martin Kolb - European Respiratory Journal 2022 被引用: 185

  14. Matrix abnormalities in pulmonary fibrosis

    著者: Chandak Upagupta, Chiko Shimbori, Rahmah Alsilmi, Martin Kolb - European Respiratory Review 2018 被引用: 277

  15. Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline

    著者: Ganesh Raghu, Sydney B. Montesi, Richard M. Silver, Tanzib Hossain, Madalina Macrea, Derrick Herman, Hayley Barnes, Ayodeji Adegunsoye, Arata Azuma, Leland W.K. Chung, Gregory C. Gardner, Kristin B. Highland, Marie Hudson, Robert J. Kaner, Martin Kolb, Mary Beth Scholand, Virginia Steen, Carey C. Thomson, Elizabeth R. Volkmann, Fredrick M. Wigley, Dee Burlile, Karen Kemper, Shandra L. Knight, Marya Ghazipura - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 160

  16. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases

    著者: Lutz Wollin, Jörg H. W. Distler, Elizabeth F. Redente, David W. H. Riches, Susanne Stowasser, Rozsa Schlenker‐Herceg, Toby M. Maher, Martin Kolb - European Respiratory Journal 2019 被引用: 296

  17. What's in a name? That which we call IPF, by any other name would act the same

    著者: Athol U. Wells, Kevin K. Brown, Kevin R. Flaherty, Martin Kolb, Victor J. Thannickal - European Respiratory Journal 2018 被引用: 352

  18. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis

    著者: Martin Kolb, Peter J. Margetts, Daniel C. Anthony, Fernando J. Pitossi, Jack Gauldie - Journal of Clinical Investigation 2001 被引用: 741

  19. Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice

    著者: Tina Bormann, Regina Maus, Jennifer Stolper, Meritxell Tort Tarrés, Christina Brandenberger, Dirk Wedekind, Danny Jonigk, Tobias Welte, Jack Gauldie, Martin Kolb, Ulrich A. Maus - Respiratory Research 2022 被引用: 92

  20. The natural history of progressive fibrosing interstitial lung diseases

    著者: Martin Kolb, Martina Vašáková - Respiratory Research 2019 被引用: 266

  21. Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial

    著者: Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker‐Herceg, Kevin K. Brown - European Respiratory Journal 2021 被引用: 115

  22. Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis

    著者: Martin Kolb, Bruno Crestani, Toby M. Maher - European Respiratory Review 2023 被引用: 74

  23. M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner

    著者: Tamara Krneta, Amy Gillgrass, Sophie M. Poznanski, Marianne V. Chew, Amanda J. Lee, Martin Kolb, Ali A. Ashkar - Journal of Leukocyte Biology 2016 被引用: 112

  24. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial

    著者: Eric L. Matteson, Martin Aringer, Gerd R Burmester, Heiko Mueller, Lizette Moros, Martin Kolb - Clinical Rheumatology 2023 被引用: 76